{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:12:33Z","timestamp":1754161953240,"version":"3.41.2"},"reference-count":92,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443296383"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA049886","DA058666","DA011792","AA029023","DA043204"],"award-info":[{"award-number":["DA049886","DA058666","DA011792","AA029023","DA043204"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.irn.2024.08.001","type":"book-chapter","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T15:24:01Z","timestamp":1723908241000},"page":"383-399","source":"Crossref","is-referenced-by-count":0,"title":["GABAergic compounds for the treatment of alcohol use disorder"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.irn.2024.08.001_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fnins.2014.00140","article-title":"GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence","volume":"8","author":"Agabio","year":"2014","journal-title":"Frontiers in Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2024.08.001_bib2","first-page":"CD005063","article-title":"Benzodiazepines for alcohol withdrawal","author":"Amato","year":"2010","journal-title":"Cochrane Database of Systematic Reviews (Online)"},{"key":"10.1016\/bs.irn.2024.08.001_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for 5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/jpet.109.158303","article-title":"Reducing abuse liability of GABAA\/benzodiazepine ligands via selective partial efficacy at alpha1 and alpha2\/3 subtypes","volume":"332","author":"Ator","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2024.08.001_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/alcalc\/agab003","article-title":"Recent advances in the potential of positive allosteric modulators of the GABAB receptor to treat alcohol use disorder","volume":"56","author":"Augier","year":"2021","journal-title":"Alcohol and Alcoholism (Oxford, Oxfordshire)"},{"issue":"5","key":"10.1016\/bs.irn.2024.08.001_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/acer.14000","article-title":"GABA(A) receptor subtypes and the abuse-related effects of ethanol in rhesus monkeys: Experiments with selective positive allosteric modulators","volume":"43","author":"Berro","year":"2019","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/bs.irn.2024.08.001_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0091-3057(97)00034-8","article-title":"Discriminative stimulus properties of ethanol in the rat: Differential effects of selective and nonselective benzodiazepine receptor agonists","volume":"58","author":"Bienkowski","year":"1997","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.irn.2024.08.001_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-3565(24)38150-9","article-title":"Ethanol-like discriminative stimulus effects of endogenous neuroactive steroids: Effects of ethanol training dose and dosing procedure","volume":"289","author":"Bowen","year":"1999","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2024.08.001_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0091-3057(93)90338-T","article-title":"Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats","volume":"46","author":"Boyle","year":"1993","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.irn.2024.08.001_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.alcohol.2017.03.002","article-title":"Persistent negative effects of alcohol drinking on aspects of novelty-directed behavior in male rhesus macaques","volume":"63","author":"Chandler","year":"2017","journal-title":"Alcohol (Fayetteville, N. Y.)"},{"key":"10.1016\/bs.irn.2024.08.001_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2017_80","article-title":"GABAA receptor subtype mechanisms and the abuse-related effects of ethanol: Genetic and pharmacological evidence","volume":"248","author":"Chandler","year":"2018","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2024.08.001_bib12","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00213-018-5163-6","article-title":"\u03b15GABAA subunit-containing receptors and sweetened alcohol cue-induced reinstatement and active sweetened alcohol self-administration in male rats","volume":"236","author":"Chandler","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108785","article-title":"Modulation of relapse-like drinking in male Sprague-Dawley rats by ligands targeting the \u03b15GABAA receptor","volume":"199","author":"Chandler","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0269881111408463","article-title":"Substitution therapy for alcoholism: time for a reappraisal?","volume":"26","author":"Chick","year":"2012","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"1","key":"10.1016\/bs.irn.2024.08.001_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mcna.2021.08.003","article-title":"The spectrum of alcohol use: Epidemiology, diagnosis, and treatment","volume":"106","author":"Cohen","year":"2022","journal-title":"The Medical Clinics of North America"},{"issue":"3","key":"10.1016\/bs.irn.2024.08.001_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/alcalc\/agae018","article-title":"Positive allosteric modulators of the GABAB receptor: A new class of ligands with therapeutic potential for alcohol use disorder","volume":"59","author":"Colombo","year":"2024","journal-title":"Alcohol and Alcoholism (Oxford, Oxfordshire)"},{"issue":"1","key":"10.1016\/bs.irn.2024.08.001_bib17","first-page":"58","article-title":"Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence","volume":"24","author":"Colombo","year":"2000","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"8","key":"10.1016\/bs.irn.2024.08.001_bib18","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.alc.0000175073.94575.86","article-title":"Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol","volume":"29","author":"Cook","year":"2005","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1016\/bs.irn.2024.08.001_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1369-1600.2012.00448.x","article-title":"Baclofen effects on alcohol seeking, self-administration and extinction of seeking responses in a within-session design in baboons","volume":"19","author":"Duke","year":"2014","journal-title":"Addiction Biology"},{"key":"10.1016\/bs.irn.2024.08.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108985","article-title":"Tolerance and dependence following chronic alprazolam treatment in rhesus monkeys: Role of GABA(A) receptor subtypes","volume":"228","author":"Duke","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.irn.2024.08.001_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1060949","article-title":"GABAA receptor subtypes and benzodiazepine use, misuse, and abuse","volume":"13","author":"Engin","year":"2023","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2024.08.001_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ajhp\/52.7.697","article-title":"Management of alcohol withdrawal","volume":"52","author":"Erstad","year":"1995","journal-title":"American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists"},{"issue":"13","key":"10.1016\/bs.irn.2024.08.001_bib23","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/molecules25133093","article-title":"The GABA(B) receptor-structure, ligand binding and drug development","volume":"25","author":"Evenseth","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/bs.irn.2024.08.001_bib24","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/dar.12841","article-title":"Prescribed sedative and other psychotropic medication use among clients attending alcohol and other drug treatment","volume":"37","author":"Foulds","year":"2018","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/bs.irn.2024.08.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108299","article-title":"Neurosteroids (allopregnanolone) and alcohol use disorder: From mechanisms to potential pharmacotherapy","volume":"240","author":"Gatta","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.irn.2024.08.001_bib26","first-page":"139","article-title":"Attenuation of the discriminative stimulus effects of ethanol by the benzodiazepine partial inverse agonist Ro 15-4513","volume":"8","author":"Gatto","year":"1997","journal-title":"Behavioural Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2024.08.001_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/pds.4952","article-title":"Changes in emergency department visits for zolpidem-attributed adverse drug reactions after FDA Drug Safety Communications","volume":"29","author":"Geller","year":"2020","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/bs.irn.2024.08.001_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02247439","article-title":"Ethanol-like discriminative stimulus effects of the neurosteroid 3a-hydroxy-5a-pregnan-20-one in female Macaca fascicularis monkeys","volume":"124","author":"Grant","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s002130050211","article-title":"Discriminative stimulus effects of ethanol and 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis)","volume":"130","author":"Grant","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.108.137315","article-title":"Neuroactive steroid stereospecificity of ethanol-like discriminative stimulus effects in monkeys","volume":"326","author":"Grant","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2024.08.001_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002130000510","article-title":"Characterization of the discriminative stimulus effects of GABA(A) receptor ligands in Macaca fascicularis monkeys under different ethanol training conditions","volume":"152","author":"Grant","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.irn.2024.08.001_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/jpet.109.156810","article-title":"Antagonism of the ethanol-like discriminative stimulus effects of ethanol, pentobarbital, and midazolam in cynomolgus monkeys reveals involvement of specific GABAA receptor subtypes","volume":"331","author":"Helms","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2024.08.001_bib33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1530-0277.2008.00674.x","article-title":"Zolpidem generalization and antagonism in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g\/kg ethanol","volume":"32","author":"Helms","year":"2008","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/bs.irn.2024.08.001_bib34","first-page":"10","article-title":"Neurosteroid influences on sensitivity to ethanol","volume":"3","author":"Helms","year":"2012","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"key":"10.1016\/bs.irn.2024.08.001_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2016.10.036","article-title":"Effects of the benzodiazepine GABAA \u03b11-preferring antagonist 3-isopropoxy-\u03b2-carboline hydrochloride (3-ISOPBC) on alcohol seeking and self-administration in baboons","volume":"170","author":"Holtyn","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.irn.2024.08.001_bib36","doi-asserted-by":"crossref","unstructured":"Holtyn, A. F., & Weerts, E. M. (2022). GABAB receptors and alcohol use disorders: Preclinical studies. Current Topics in Behavioral Neurosciences, 52, 157\u2013194.","DOI":"10.1007\/7854_2020_178"},{"issue":"6","key":"10.1016\/bs.irn.2024.08.001_bib37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/02698811211058967","article-title":"A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects","volume":"36","author":"Ito","year":"2022","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2024.08.001_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-002-1294-9","article-title":"Lorazepam substitutes for the alcohol stimulus in social drinkers","volume":"166","author":"Jackson","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib39","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1523\/JNEUROSCI.21-06-02166.2001","article-title":"GABAA receptors containing 5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: An extended ethanol reward circuitry","volume":"21","author":"June","year":"2001","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2024.08.001_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00213-012-2946-z","article-title":"Effects of the benzodiazepine GABAA alpha1-preferring ligand, 3-propoxy-beta-carboline hydrochloride (3-PBC), on alcohol seeking and self-administration in baboons","volume":"227","author":"Kaminski","year":"2013","journal-title":"Psychopharmacology"},{"issue":"6622","key":"10.1016\/bs.irn.2024.08.001_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/386239a0","article-title":"Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors","volume":"386","author":"Kaupmann","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2024.08.001_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114777","article-title":"Zolpidem use and risk of suicide: A systematic review and meta-analysis","volume":"316","author":"Khan","year":"2022","journal-title":"Psychiatry Research"},{"key":"10.1016\/bs.irn.2024.08.001_bib43","first-page":"385","article-title":"The use of psychoactive drugs in the long-term treatment of chronic alcoholics","volume":"252","author":"Kissin","year":"1975"},{"issue":"17","key":"10.1016\/bs.irn.2024.08.001_bib44","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1021\/acschemneuro.0c00295","article-title":"Imidazodiazepine anticonvulsant, KRM-II-81, produces novel, non-diazepam-like antiseizure effects","volume":"11","author":"Knutson","year":"2020","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2024.08.001_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41386-019-0446-0","article-title":"Alcohol use disorder and sleep disturbances: A feed-forward allostatic framework","volume":"45","author":"Koob","year":"2020","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2024.08.001_bib46","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00213-018-4918-4","article-title":"GABA(A) receptor polymorphisms in alcohol use disorder in the GWAS era","volume":"235","author":"Koulentaki","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pneurobio.2003.09.001","article-title":"Neurosteroid modulation of GABAA receptors","volume":"71","author":"Lambert","year":"2003","journal-title":"Progress in Neurobiology"},{"issue":"6","key":"10.1016\/bs.irn.2024.08.001_bib48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/alcalc\/agx072","article-title":"Baclofen self-poisoning in the era of changing indication: Multicentric reports to a french poison control centre","volume":"52","author":"L\u00e9ger","year":"2017","journal-title":"Alcohol and Alcoholism (Oxford, Oxfordshire)"},{"issue":"1","key":"10.1016\/bs.irn.2024.08.001_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"5","key":"10.1016\/bs.irn.2024.08.001_bib50","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0026-895X(25)10192-2","article-title":"Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors","volume":"45","author":"L\u00fcddens","year":"1994","journal-title":"Molecular Pharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2024.08.001_bib51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.alcohol.2009.09.030","article-title":"Role of the GABA(B) receptor in alcohol-seeking and drinking behavior","volume":"43","author":"Maccioni","year":"2009","journal-title":"Alcohol (Fayetteville, N. Y.)"},{"issue":"4","key":"10.1016\/bs.irn.2024.08.001_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00213-003-1671-z","article-title":"A high affinity ligand for GABAA-receptor containing alpha5 subunit antagonizes ethanol's neurobehavioral effects in Long-Evans rats","volume":"172","author":"McKay","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yhbeh.2017.07.015","article-title":"Activation of extrasynaptic delta-GABA(A) receptors globally or within the posterior-VTA has estrous-dependent effects on consumption of alcohol and estrous-independent effects on locomotion","volume":"95","author":"Mel\u00f3n","year":"2017","journal-title":"Hormones and Behavior"},{"issue":"3","key":"10.1016\/bs.irn.2024.08.001_bib54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0269881119882803","article-title":"Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for alpha3 subunit-containing GABA(A) receptors","volume":"34","author":"Meng","year":"2020","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2024.08.001_bib55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0091-3057(91)90239-X","article-title":"Effects of Ro 15-4513 on ethanol discrimination in C57BL\/6 mice","volume":"38","author":"Middaugh","year":"1991","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.irn.2024.08.001_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00213-022-06278-3","article-title":"Pregnenolone effects on provoked alcohol craving, anxiety, HPA axis, and autonomic arousal in individuals with alcohol use disorder","volume":"240","author":"Milivojevic","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/bs.irn.2024.08.001_bib57","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamainternmed.2018.3031","article-title":"Assessment of patterns of potentially unsafe use of zolpidem","volume":"178","author":"Moore","year":"2018","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/bs.irn.2024.08.001_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2007.07.011","article-title":"GABAergic modulation of binge-like ethanol intake in C57BL\/6J mice","volume":"88","author":"Moore","year":"2007","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"6","key":"10.1016\/bs.irn.2024.08.001_bib59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1192\/bjp.2018.13","article-title":"Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial","volume":"212","author":"Morley","year":"2018","journal-title":"The British Journal of Psychiatry: the Journal of Mental Science"},{"issue":"2","key":"10.1016\/bs.irn.2024.08.001_bib60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/acer.14253","article-title":"A rationale for allopregnanolone treatment of alcohol use disorders: Basic and clinical studies","volume":"44","author":"Morrow","year":"2020","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"14","key":"10.1016\/bs.irn.2024.08.001_bib61","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/bph.13509","article-title":"GPCRdb: The G protein-coupled receptor database\u2014An introduction","volume":"173","author":"Munk","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib62","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.neuropharm.2007.08.008","article-title":"Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist","volume":"53","author":"Nutt","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109735","article-title":"Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers","volume":"243","author":"Pareek","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/bs.irn.2024.08.001_bib64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-005-0231-0","article-title":"Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol","volume":"186","author":"Pierucci-Lagha","year":"2006","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2024.08.001_bib65","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ddr.22042","article-title":"Comparative anticonvulsant activity of the GABAkine KRM-II-81 and a deuterated analog","volume":"84","author":"Ping","year":"2023","journal-title":"Drug Development Research"},{"key":"10.1016\/bs.irn.2024.08.001_bib66","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1124\/jpet.104.080275","article-title":"Contribution of alpha1GABAA and alpha5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys","volume":"313","author":"Platt","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2024.08.001_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1100\/tsw.2007.203","article-title":"Neurophysiological endophenotypes, CNS disinhibition, and risk for alcohol dependence and related disorders","volume":"7","author":"Porjesz","year":"2007","journal-title":"The Scientific World Journal"},{"key":"10.1016\/bs.irn.2024.08.001_bib68","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1530-0277.2011.01551.x","article-title":"Alteration of ethanol drinking in mice via modulation of the GABAA receptor with ganaxolone, finasteride, and gaboxadol","volume":"35","author":"Ramaker","year":"2011","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"4","key":"10.1016\/bs.irn.2024.08.001_bib69","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuropharm.2012.05.007","article-title":"Effect of ganaxolone and THIP on operant and limited-access ethanol self-administration","volume":"63","author":"Ramaker","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib70","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-3565(25)24435-4","article-title":"Attenuation of the discriminative stimulus properties of ethanol and oxazepam, but not of pentobarbital, by Ro 15-4513 in mice","volume":"244","author":"Rees","year":"1988","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"7","key":"10.1016\/bs.irn.2024.08.001_bib71","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/add.14927","article-title":"Titrated baclofen for high-risk alcohol consumption: A randomized placebo-controlled trial in out-patients with 1-year follow-up","volume":"115","author":"Rigal","year":"2020","journal-title":"Addiction (Abingdon, England)"},{"issue":"1","key":"10.1016\/bs.irn.2024.08.001_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cns.12489","article-title":"Pharmacotherapy for alcohol dependence: The 2015 recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies","volume":"22","author":"Rolland","year":"2016","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2024.08.001_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00213-005-0228-8","article-title":"Anti-conflict effects of benzodiazepines in rhesus monkeys: Relationship with therapeutic doses in humans and role of GABAA receptors","volume":"184","author":"Rowlett","year":"2006","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2024.08.001_bib74","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/acer.12018","article-title":"Modulation of \u03b15 subunit-containing GABAA receptors alters alcohol drinking by rhesus monkeys","volume":"37","author":"R\u00fcedi-Bettschen","year":"2013","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/bs.irn.2024.08.001_bib75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00008877-199708000-00002","article-title":"The effects of new hypnotic drugs in rats trained to discriminate ethanol","volume":"8","author":"Sanger","year":"1997","journal-title":"Behavioural Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2024.08.001_bib76","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/acer.12320","article-title":"Little evidence of a role for the alpha1GABAA subunit-containing receptor in a rhesus monkey model of alcohol drinking","volume":"38","author":"Sawyer","year":"2014","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/bs.irn.2024.08.001_bib77","first-page":"11","article-title":"Benzodiazepine dependency in alcoholics","volume":"45","author":"Schuster","year":"1981","journal-title":"Connecticut Medicine"},{"key":"10.1016\/bs.irn.2024.08.001_bib78","first-page":"161","article-title":"Relationship between the discriminative stimulus properties and subjective effects of drugs","volume":"4","author":"Schuster","year":"1988","journal-title":"Psychopharmacology Series"},{"key":"10.1016\/bs.irn.2024.08.001_bib79","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1530-0277.2002.tb02601.x","article-title":"Discriminative stimulus effects of ethanol in C57BL\/6J and DBA\/2J inbred mice","volume":"26","author":"Shelton","year":"2002","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"6","key":"10.1016\/bs.irn.2024.08.001_bib80","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/npp.2012.265","article-title":"Reinforcing effects of compounds lacking intrinsic efficacy at \u03b11 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys","volume":"38","author":"Shinday","year":"2013","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2024.08.001_bib81","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/JCP.0000000000000786","article-title":"Thirty- versus ten-day diazepam treatment for alcohol detoxification and a comparison of drinking patterns, craving, and anxiety for up to 12 weeks: A \u201cproof-of-concept\u201d open-label randomized controlled trial","volume":"37","author":"Simioni","year":"2017","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib82","first-page":"227","article-title":"GABAergic involvement in the acquisition of voluntary ethanol intake in laboratory rats","volume":"27","author":"Smith","year":"1992","journal-title":"Alcohol and Alcoholism (Oxford, Oxfordshire)"},{"issue":"1-3","key":"10.1016\/bs.irn.2024.08.001_bib83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2005.09.031","article-title":"Role of GABAA alpha5-containing receptors in ethanol reward: The effects of targeted gene deletion, and a selective inverse agonist","volume":"526","author":"Stephens","year":"2005","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.08.001_bib84","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm031076j","article-title":"Selective, orally active -aminobutyric acidA 5 receptor inverse agonists as cognition enhancers","volume":"47","author":"Sternfeld","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2024.08.001_bib85","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00001756-199806010-00018","article-title":"Alcohol modulation of single GABAA receptor-channel kinetics","volume":"9","author":"Tatebayashi","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/bs.irn.2024.08.001_bib86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.irn.2024.03.002","article-title":"GABAergic mechanisms in alcohol dependence","volume":"175","author":"Uusi-Oukari","year":"2024","journal-title":"International Review of Neurobiology"},{"issue":"3","key":"10.1016\/bs.irn.2024.08.001_bib87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cpdd.766","article-title":"Single- and multiple-dose safety, tolerability, and pharmacokinetic profiles of ASP8062: Results from 2 phase 1 studies","volume":"9","author":"Walzer","year":"2020","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"10.1016\/bs.irn.2024.08.001_bib88","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1749-6632.1999.tb11341.x","article-title":"Molecular and functional diversity of the expanding GABAA receptor gene family","volume":"868","author":"Whiting","year":"1999","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.irn.2024.08.001_bib89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-3057(97)00584-4","article-title":"The abuse potential of zolpidem administered alone and with alcohol","volume":"60","author":"Wilkinson","year":"1998","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.irn.2024.08.001_bib90","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/alcalc\/agl076","article-title":"Diazepam dose-dependently increases or decreases implicit priming of alcohol associations in problem drinkers","volume":"41","author":"Zack","year":"2006","journal-title":"Alcohol and Alcoholism (Oxford, Oxfordshire)"},{"key":"10.1016\/bs.irn.2024.08.001_bib91","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1530-0277.1999.tb04041.x","article-title":"Clinical use of benzodiazepines and decreased memory activation in anxious problem drinkers","volume":"23","author":"Zack","year":"1999","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"4","key":"10.1016\/bs.irn.2024.08.001_bib92","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MJT.0b013e3181d169ed","article-title":"Zolpidem misuse with other medications or alcohol frequently results in intensive care unit admission","volume":"18","author":"Zosel","year":"2011","journal-title":"American Journal of Therapeutics"}],"container-title":["International Review of Neurobiology","Advances in Alcohol Use Disorder Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774224001041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774224001041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T14:05:42Z","timestamp":1753797942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774224001041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443296383"],"references-count":92,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2024.08.001","relation":{},"ISSN":["0074-7742"],"issn-type":[{"type":"print","value":"0074-7742"}],"subject":[],"published":{"date-parts":[[2024]]}}}